Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status
- PMID: 3892914
- PMCID: PMC1305982
Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status
Abstract
The insulin response to glucose taken orally is increased in patients with impaired glucose tolerance (IGT) but decreased in those with type II diabetes mellitus. The insulin response to meals, however, is normal in patients with type II diabetes, although the glucose concentrations are obviously elevated. The acute insulin response to intravenously administered glucose is absent in cases of both IGT and type II diabetes when the fasting plasma glucose level exceeds 115 mg per dl. On the other hand, the response to other intravenously given secretagogues is either normal or nearly so. The absent acute insulin response to intravenously administered glucose can be restored by alpha-adrenergic blockade, prostaglandin synthesis inhibition, dopaminergic blockade and euglycemia. Insulin antagonism characterizes patients with both IGT and type II diabetes. Those with IGT and mild diabetes mellitus (untreated fasting plasma glucose concentrations < 180 mg per dI) have a receptor defect probably due to down regulation. Diabetic patients with more severe type II diabetes show a postreceptor defect. The relation (if any) between receptor and postreceptor defects is unclear.
Similar articles
-
Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.Diabetes. 2008 Jun;57(6):1638-44. doi: 10.2337/db07-0954. Epub 2008 Mar 10. Diabetes. 2008. PMID: 18332099
-
Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.Acta Diabetol. 2004 Jun;41(2):70-6. doi: 10.1007/s00592-004-0147-x. Acta Diabetol. 2004. PMID: 15224208
-
Insulin action and insulin secretion in identical twins with MODY. Evidence for defects in both insulin action and secretion.Diabetes. 1988 Jun;37(6):730-5. doi: 10.2337/diab.37.6.730. Diabetes. 1988. PMID: 3289993
-
Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.Diabetes Care. 2006 May;29(5):1130-9. doi: 10.2337/diacare.2951130. Diabetes Care. 2006. PMID: 16644654 Review.
-
The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes.Diabetes Care. 1984 May-Jun;7 Suppl 1:81-8. Diabetes Care. 1984. PMID: 6376033 Review.
Cited by
-
Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.Diabetologia. 2016 May;59(5):907-17. doi: 10.1007/s00125-016-3899-2. Epub 2016 Feb 19. Diabetologia. 2016. PMID: 26894277 Review.
-
Higher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities?Diabetes Ther. 2014 Dec;5(2):459-69. doi: 10.1007/s13300-014-0082-y. Epub 2014 Sep 18. Diabetes Ther. 2014. PMID: 25230877 Free PMC article.
-
Type II diabetes mellitus.West J Med. 1985 Jun;142(6):834-5. West J Med. 1985. PMID: 4024639 Free PMC article. No abstract available.
-
Peripheral Gonadotropin-Inhibitory Hormone (GnIH) Acting as a Novel Modulator Involved in Hyperphagia-Induced Obesity and Associated Disorders of Metabolism in an In Vivo Female Piglet Model.Int J Mol Sci. 2022 Nov 12;23(22):13956. doi: 10.3390/ijms232213956. Int J Mol Sci. 2022. PMID: 36430435 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical